Why the study?
Does intravenous lidocaine alter hemodynamic parameters in patients with non-ischemic heart disease?
Does intravenous lidocaine alter hemodynamic parameters in patients with non-ischemic heart disease?
Intravenous lidocaine is well tolerated and does not cause significant hemodynamic changes in patients with non-ischemic heart disease.
Answers are grounded in this paper and cite their sources.
Lidocaine may be hemodynamically neutral in non-ischemic disease; case report leaves open need for controlled confirmation before practice change.
Lidocaine is currently one of the most used drugs in ventricular arrhythmias, especially in acute myocardial infarction. Only few series subjected to hemodynamic studies have hitherto been reported. The author studied the hemodynamic changes following the intravenous injection of lidocaine to 12 cases with non‐ischemic heart disease. After a bolus dose of 50 or 100 mg an infusion was started with 1 or 2 mg/min for 20 minutes. No significant changes were found in mean values for heart rate, cardiac output, stroke volume, mean systemic and pulmonary artery pressures or peripheral arterial resistance. It was well tolerated in all cases, including one with total A‐V block. The serum lidocaine concentration was determined in eight cases.
No takes yet. Share an insight, caveat, or question.
I Cullhed (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: